2024 Enliven therapeutics stock price

Enliven therapeutics stock price

Author: yyao

August undefined, 2024

WebEnliven Therapeutics, Inc. Common Stock (ELVN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. WebApr 10, 2024 · 3 Wall Street analysts have issued 1 year target prices for Enliven Therapeutics' shares. Their ELVN share price forecasts range from $27.00 to $27.00. On …

Statement of Ownership (sc 13g)

WebMar 21, 2024 · Explanatory Note. On March 1, 2024, Enliven Therapeutics, Inc. (the “ Company ”) filed a Current Report on Form 8-K (the “ Initial Form 8-K ”) to report, among other things, the completion of a previously announced merger pursuant to which Iguana Merger Sub, Inc. merged with and into Enliven Inc. (formerly, Enliven Therapeutics, … WebMar 31, 2024 · Presently, Enliven Therapeutics Inc. shares are logging -12.59% during the 52-week period from high price, and 468.59% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.90 and $25.34. deakin university media releases

Enliven Therapeutics, Inc. (ELVN) Price Book Value - Zacks.com

Web19 hours ago · The Investor Relations website contains information about Enliven Therapeutics's business for stockholders, potential investors, and financial analysts. WebApr 11, 2024 · Price Book Value is a widely used stock evaluation measure. Find the latest Price Book Value for Enliven Therapeutics, Inc. (ELVN) WebEnliven Therapeutics, Inc. Limited operates as an agricultural biotechnology company. The Company focuses on discovery and development of medicine, oncology therapeutics, … deakin university medical school

ELVN - Enliven Therapeutics Inc Stock quote - CNNMoney.com

WebEnliven Therapeutics 6200 Lookout Road Boulder, CO 80301 (720) 647-8519. Business & Media Inquiries: [email protected]. Employment Inquiries: WebApr 3, 2024 · Stock Quote & Chart Historic Price Lookup Analyst Coverage Corporate Governance Docs and Charters Management Board of Directors Financials & Filings SEC Filings IR Resources Email Alerts Contact Us Careers Values Job Opportunities Contact Privacy Policy Terms of Use 6200 Lookout Road Boulder, CO 80301 General & … generalized dynamic wakeWebFind the latest Enliven Therapeutics, Inc. (ELVN) stock quote, history, news and other vital information to help you with your stock trading and investing. deakin university mobile app

"WebOct 14, 2024 · In support of the merger, Enliven also intends to raise approximately $165 million in a concurrent private financing co-led by new investors Fairmount and Venrock Healthcare Capital Partners,... " - Enliven therapeutics stock price

Enliven therapeutics stock price

Portfolio Company Imara Announces Merger Agreement with Enliven …

WebApr 13, 2024 · According to 9 analysts, the average rating for ELVN stock is "Buy." The 12-month stock price forecast is $32.64, which is an increase of 69.56% from the latest price. Web1 day ago · Enliven Therapeutics, Inc. (ELVN) (Delayed Data from NSDQ) $20.72 USD -0.73 (-3.40%) Updated Apr 10, 2024 04:00 PM ET After-Market: $20.45 -0.27 (-1.30%) …

Did you know?

WebMar 20, 2024 · ENLV Complete Enlivex Therapeutics Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebView the latest Enliven Therapeutics Inc. (ELVN) stock price, news, historical charts, analyst ratings and financial information from WSJ. ELVN Enliven Therapeutics Inc. …

WebGet the latest Enliven Therapeutics Inc (ELVN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebFeb 23, 2024 · Following the reverse stock split and closing of the merger, there are approximately 41.1 million shares of the combined company's common stock outstanding, with prior Imara stockholders owning ...

WebGet an overview of key company metrics for Enliven Therapeutics, Inc. from Zacks.com. Our Research. Your Success. WebFeb 23, 2024 · Press Releases. Year. 2024. Date. Title. View. February 23, 2024. Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 Million. PDF Version.

WebApr 11, 2024 · A high-level overview of Enliven Therapeutics, Inc. (ELVN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …

Web1 day ago · Enliven Therapeutics, Inc. (ELVN) Quote Overview » Zacks Research » Enliven Therapeutics, Inc. (ELVN) Style Scores Trades from $ 1 Enliven Therapeutics, Inc. - Hold deakin university mpaWebApr 6, 2024 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Enliven Therapeutics stock is Buy based on the current 3 buy ratings for ELVN. The average twelve-month price prediction for Enliven Therapeutics is $27.00 with a high price target of $27.00 and a low price target of $27.00. deakin university mphWebApr 3, 2024 · March 28, 2024. $23.49. 40,028. 1:1. $23.08. $23.71. $22.91. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account … generalized ecchymosisWebApr 11, 2024 · Click to get this free report Westamerica Bancorporation (WABC): Free Stock Analysis Report Disc Medicine, Inc. (IRON): Free Stock Analysis Report Enliven Therapeutics, Inc. (ELVN): Free Stock ... deakin university nurse practitionerWebNovel Insights,Precision Therapeutics. We are developing kinase inhibitors that enhance efficacy through better selectivity and combinability, combat resistance, address brain … deakin university modern slavery statementWebELVN - Enliven Therapeutics Stock Barchart Opinion - Barchart.com Enliven Therapeutics Inc (ELVN) Tutorial Alerts Watch Help Go To: Overall Average: 64% Buy Overall Average Signal calculated from all 13 indicators. generalized dynamic inversion controlWebEnliven Therapeutics, Inc. (ELVN) (Delayed Data from NSDQ) $20.72 USD -0.73 (-3.40%) Updated Apr 10, 2024 04:00 PM ET After-Market: $20.45 -0.27 (-1.30%) 7:58 PM ET Add to portfolio Zacks Rank:... generalized eigenvalue problem physics